McKesson (MCK) Competitors $706.12 +3.18 (+0.45%) Closing price 03:59 PM EasternExtended Trading$694.76 -11.36 (-1.61%) As of 05:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MCK vs. HOLX, HQY, HSIC, MMSI, AMN, CRL, HUM, ITGR, WST, and CORShould you be buying McKesson stock or one of its competitors? The main competitors of McKesson include Hologic (HOLX), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Charles River Laboratories International (CRL), Humana (HUM), Integer (ITGR), West Pharmaceutical Services (WST), and Cencora (COR). These companies are all part of the "medical" sector. McKesson vs. Its Competitors Hologic HealthEquity Henry Schein Merit Medical Systems AMN Healthcare Services Charles River Laboratories International Humana Integer West Pharmaceutical Services Cencora Hologic (NASDAQ:HOLX) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation. Which has preferable valuation and earnings, HOLX or MCK? McKesson has higher revenue and earnings than Hologic. Hologic is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHologic$4.03B3.71$789.50M$2.4127.87McKesson$359.05B0.24$3.30B$25.0828.15 Is HOLX or MCK more profitable? Hologic has a net margin of 13.79% compared to McKesson's net margin of 0.84%. Hologic's return on equity of 19.69% beat McKesson's return on equity.Company Net Margins Return on Equity Return on Assets Hologic13.79% 19.69% 10.82% McKesson 0.84%-196.66%5.66% Which has more risk & volatility, HOLX or MCK? Hologic has a beta of 0.49, suggesting that its stock price is 51% less volatile than the S&P 500. Comparatively, McKesson has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Does the media refer more to HOLX or MCK? In the previous week, McKesson had 19 more articles in the media than Hologic. MarketBeat recorded 34 mentions for McKesson and 15 mentions for Hologic. Hologic's average media sentiment score of 1.47 beat McKesson's score of 1.35 indicating that Hologic is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hologic 11 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 25 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend HOLX or MCK? Hologic currently has a consensus price target of $78.00, indicating a potential upside of 16.12%. McKesson has a consensus price target of $725.10, indicating a potential upside of 2.69%. Given Hologic's higher probable upside, analysts clearly believe Hologic is more favorable than McKesson.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hologic 0 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.59McKesson 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.85 Do insiders and institutionals have more ownership in HOLX or MCK? 94.7% of Hologic shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 1.9% of Hologic shares are owned by company insiders. Comparatively, 0.1% of McKesson shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryHologic and McKesson tied by winning 8 of the 16 factors compared between the two stocks. Get McKesson News Delivered to You Automatically Sign up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MCK vs. The Competition Export to ExcelMetricMcKessonMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$87.83B$15.33B$5.74B$20.87BDividend Yield0.42%1.50%4.53%3.60%P/E Ratio28.1517.9430.4528.31Price / Sales0.242.44392.5852.52Price / Cash17.4216.3237.0323.77Price / Book-55.303.728.955.19Net Income$3.30B$472.13M$3.26B$992.10M7 Day Performance4.68%-0.46%1.06%-0.30%1 Month Performance-0.71%2.89%4.31%1.19%1 Year Performance26.49%13.03%28.40%10.49% McKesson Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MCKMcKesson4.25 of 5 stars$706.12+0.5%$725.10+2.7%+28.0%$87.83B$359.05B28.1545,000Positive NewsInsider TradeHOLXHologic4.8237 of 5 stars$67.99-0.1%$77.83+14.5%-15.0%$15.12B$4.03B28.217,063Positive NewsAnalyst UpgradeHQYHealthEquity4.1662 of 5 stars$92.46-0.6%$118.55+28.2%+20.4%$8.00B$1.20B67.493,120Positive NewsHSICHenry Schein4.1867 of 5 stars$66.10+0.2%$75.58+14.3%-0.5%$8.02B$12.67B21.3225,000Positive NewsMMSIMerit Medical Systems4.4158 of 5 stars$84.04-1.8%$107.00+27.3%-3.9%$4.98B$1.36B42.667,400Positive NewsAMNAMN Healthcare Services4.3746 of 5 stars$16.46-4.6%$30.25+83.8%-59.9%$629.98M$2.85B-2.122,968CRLCharles River Laboratories International4.7454 of 5 stars$148.75+0.0%$175.69+18.1%-21.4%$7.32B$4.05B-111.8420,100Positive NewsInsider TradeHUMHumana4.2542 of 5 stars$267.19+0.2%$281.62+5.4%-18.7%$32.13B$117.76B20.5165,680Positive NewsAnalyst ForecastAnalyst RevisionITGRInteger4.1434 of 5 stars$105.44-0.9%$140.25+33.0%-12.1%$3.69B$1.72B46.4511,000Positive NewsAnalyst RevisionWSTWest Pharmaceutical Services4.6992 of 5 stars$240.40-0.2%$320.71+33.4%-17.8%$17.29B$2.96B35.9910,600Positive NewsAnalyst RevisionCORCencora4.2371 of 5 stars$290.78+2.0%$309.83+6.6%+27.2%$56.36B$638.56M29.9246,000Positive News Related Companies and Tools Related Companies HOLX Competitors HQY Competitors HSIC Competitors MMSI Competitors AMN Competitors CRL Competitors HUM Competitors ITGR Competitors WST Competitors COR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MCK) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding McKesson Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share McKesson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access